Tze Leng Eunice Goh

Title: Tze Leng Eunice Goh: Innovator in Antimicrobial Peptides

Introduction

Tze Leng Eunice Goh is a prominent inventor based in Singapore, known for her significant contributions to the field of antimicrobial peptides. Her innovative work focuses on modifying peptides to enhance their therapeutic properties while reducing cytotoxicity. With a patent to her name, she has made strides in the development of pharmaceutical compositions that can effectively manage microbial growth.

Latest Patents

Tze Leng Eunice Goh holds a patent for "Antimicrobial peptides comprising epsilon lysine residues." This patent describes a peptide that includes at least five amino acid residues, with modifications that enhance its antimicrobial activity while minimizing cytotoxic effects. The modifications involve substituting specific amino acids with epsilon-lysine and other residues, leading to peptides that are not only effective against microorganisms but also safer for therapeutic use. The patent outlines various applications, including pharmaceutical compositions and methods for treating proliferative diseases and inflammation.

Career Highlights

Throughout her career, Tze Leng Eunice Goh has worked with notable organizations such as Singapore Health Services Pte Ltd and Nanyang Technological University. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research in antimicrobial therapies.

Collaborations

Tze Leng Eunice Goh has collaborated with esteemed colleagues, including Lakshminarayanan Rajamani and Venkatesh Mayandi. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the realm of antimicrobial peptides.

Conclusion

Tze Leng Eunice Goh is a trailblazer in the field of antimicrobial peptides, with a focus on creating safer and more effective therapeutic options. Her contributions to science and medicine are invaluable, and her work continues to inspire future innovations in the field.